Outcomes and characteristics of COVID-19 patients treated with continuous positive airway pressure/high-flow nasal oxygen outside the intensive care setting
Background Continuous positive airway pressure (CPAP) and high-flow nasal oxygen (HFNO) have been used to manage hypoxaemic respiratory failure secondary to coronavirus disease 2019 (COVID-19) pneumonia. Limited data are available for patients treated with noninvasive respiratory support outside of...
Main Authors: | Dominic L. Sykes, Michael G. Crooks, Khaing Thu Thu, Oliver I. Brown, Theodore J.P. Tyrer, Jodie Rennardson, Catherine Littlefield, Shoaib Faruqi |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2021-10-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/7/4/00318-2021.full |
Similar Items
-
COVID-19 progression, frailty, and use of prolonged continuous positive airway pressure as a ward-based treatment: Lessons to be learnt from a case
by: Dominic L Sykes, et al.
Published: (2021-01-01) -
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective
by: Dominic L. Sykes, et al.
Published: (2021-02-01) -
Airway management: High flow nasal oxygenation
by: Ajay Kumar, et al.
Published: (2016-01-01) -
Comparison of pulsed versus continuous oxygen delivery using realistic adult nasal airway replicas
by: Chen JZ, et al.
Published: (2017-08-01) -
It is time to end our love affair with short-acting β2-agonists in asthma
by: Michael G. Crooks, et al.
Published: (2022-10-01)